Eating

Semaglutide vs Ozempic: Is Semaglutide the Same as Ozempic? (2026)

Jeff Zorn · · 11 min read

Share

By Jeff Zorn, founder of Zornava. Former college basketball player, degree in exercise science and nutrition, two years on GLP-1 medications. My experience, not medical advice. Talk to your prescriber or a registered dietitian about your own situation.

Published · Last reviewed

Short answer: semaglutide is the medicine, and Ozempic is one brand of it. Novo Nordisk sells semaglutide in the US as Ozempic (a weekly injection, and Ozempic tablets) and Rybelsus for type 2 diabetes, and as Wegovy (a weekly injection and a daily pill) for chronic weight management.[1][2][3][4] As of November 13, 2026 no generic semaglutide can be sold in the US: the one generic application has only tentative approval.[5][6] "Semaglutide" sold under no brand name is usually a compounded product, which the FDA says is not FDA-approved.[7][8]

Whatever form it comes in, the eating side is the same, and it starts with our guide to what to eat when you're eating less. General information, not medical or legal advice. Everything below comes from the FDA labels, the FDA's approval database and compounding pages, and Novo Nordisk's price pages, as of November 13, 2026. This page names no sellers and links to none.

Semaglutide vs Ozempic at a glance

What it is Who makes it FDA-approved for Form and label doses FDA-approved product?
Ozempic injection Novo Nordisk Type 2 diabetes; heart and kidney risk in type 2 diabetes[2] Weekly pen: 0.25 mg start, then 0.5, 1 or 2 mg[2] Yes (December 5, 2017)[1]
Ozempic tablets and Rybelsus Novo Nordisk Type 2 diabetes; cardiovascular risk in high-risk type 2 diabetes[4][1] Daily tablet: Ozempic tablets 1.5, 4 or 9 mg; Rybelsus 3, 7 or 14 mg; not interchangeable mg for mg[4] Yes (Rybelsus September 20, 2019; Ozempic tablet formulation December 9, 2024)[1]
Wegovy injection Novo Nordisk Chronic weight management (adults and ages 12 and up); heart risk; MASH[3] Weekly pen: 0.25 mg start; maintenance 1.7 or 2.4 mg, up to 7.2 mg in adults[3] Yes (June 4, 2021)[1]
Wegovy tablets Novo Nordisk Chronic weight management and heart risk in adults[3] Daily tablet: 1.5 mg start; maintenance 25 mg[3] Yes (December 22, 2025)[1]
Generic semaglutide injection A generic drug maker Not on sale Three injection strengths Tentative approval only (April 7, 2026), which does not allow it to be sold[5][6]
Compounded "semaglutide" A compounding pharmacy or outsourcing facility Nothing: not FDA-approved[7] Often vials and syringes, measured by the patient[9] No. The FDA does not check its safety, effectiveness or quality before sale[7]
Semaglutide sodium or semaglutide acetate Some compounders Nothing Salt forms No. The FDA says these are different active ingredients and knows of no lawful basis to compound with them[10]

Every trial result for semaglutide, including those on our semaglutide reference page, was measured on Novo Nordisk's manufactured product, not on a compounded version.[3][2]

Is semaglutide the same as Ozempic?

Ozempic is semaglutide, but semaglutide is not only Ozempic. Semaglutide is the active ingredient: a long-acting copy of GLP-1, a gut hormone released after eating, with 94% sequence homology to the human hormone.[3] Ozempic is the brand name Novo Nordisk uses for semaglutide approved for type 2 diabetes.[2]

The same molecule is sold under three brand names, for different uses and at different doses. That is why the Wegovy label says not to use it with any other semaglutide product or any other GLP-1 receptor agonist: taking Ozempic and Wegovy together would mean taking the same drug twice.[3]

Two naming points cause confusion. "Ozempic" now covers both an injection and a tablet, and the newer Ozempic tablets cannot be swapped milligram for milligram with Rybelsus.[4] And the "Wegovy pill" is a separate product, a 25 mg daily tablet approved for weight management, not for diabetes.[3]

Ozempic vs Wegovy: same drug, different label

  • Approved uses. Ozempic: blood sugar control in adults with type 2 diabetes, and lowering heart and kidney risk in adults with type 2 diabetes. Wegovy: chronic weight management, lowering the risk of heart attack, stroke and cardiovascular death in adults with heart disease and obesity or overweight, and MASH, a fatty liver disease.[2][3]
  • Doses. The Ozempic injection tops out at 2 mg a week. Wegovy's maintenance dose is 2.4 mg (or 1.7 mg), and since March 2026 up to 7.2 mg for adults.[2][3]
  • Trials. In STEP 1, the main Wegovy trial, body weight fell by an average of 14.9% over 68 weeks on 2.4 mg, against 2.4% on placebo.[11] Ozempic's approvals rest on diabetes trials such as SUSTAIN 6 and FLOW.[2]
  • Coverage. A prescription for Ozempic is written for type 2 diabetes; one for Wegovy usually for weight management. That difference, not the molecule, decides how a plan treats it.

Ozempic is not FDA-approved for chronic weight management; Wegovy is.[2][3] How Wegovy compares with Lilly's tirzepatide is on our Zepbound vs Wegovy page, and the tirzepatide side of the family is on our tirzepatide page.

Is there a generic semaglutide?

Not one you can buy in the US, as of November 13, 2026. Every semaglutide product approved for sale is a Novo Nordisk brand: Ozempic, Rybelsus, Ozempic tablets and Wegovy.[1] The FDA's database lists one generic application for a semaglutide injection, given tentative approval on April 7, 2026.[5] In the FDA's words, the agency "delays final approval of the generic drug product until all patent or exclusivity issues have been resolved," and "a tentative approval does not allow the applicant to market the generic drug product."[6]

Compounded semaglutide is not a generic. The FDA tells telehealth companies not to describe a compounded drug as "a generic version of an FDA-approved drug or the same as a drug approved by FDA."[12]

What is the "semaglutide" sold by telehealth companies and med spas?

When a clinic, med spa or website offers "semaglutide" rather than Ozempic or Wegovy, it is not selling one of the approved brands, and it is usually a compounded product. On March 3, 2026 the FDA sent warning letters to 30 telehealth companies for claims implying their compounded GLP-1 products were the same as approved drugs, and for branding that obscured who actually made them.[8] What the FDA says about these products:

  • Not approved. "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed."[7]
  • The shortage is over. Compounded copies spread while semaglutide was on the FDA shortage list, from 2022. The FDA declared the shortage resolved on February 21, 2025, and the grace periods for compounders ended on April 22, 2025 for pharmacies and May 22, 2025 for outsourcing facilities.[13][14]
  • Copies are now allowed only in narrow cases. A pharmacy may make one when a prescriber documents a change that produces a significant difference for one identified patient. "A lower price" is not enough, and adding vitamin B12 does not by itself make it something other than a copy.[15][14]
  • Salt forms. Some compounders have used semaglutide sodium and semaglutide acetate. The FDA says these are different active ingredients from the one in the approved drugs.[10]
  • Dosing errors. The FDA has reported patients drawing 5 to 20 times the intended dose from multiple-dose vials, and mix-ups between milligrams, milliliters and "units."[9]
  • Reports. As of May 31, 2026, the FDA had received 990 reports of adverse events with compounded semaglutide. Reports like these do not prove the drug caused the event.[10]
  • Counterfeits. Counterfeit Ozempic has been found in the US drug supply.[10]

The law, the court cases and the questions to ask a pharmacy are set out in full in compounded GLP-1s explained. The FDA's BeSafeRx checklist for a safe online pharmacy asks for a prescription, a US address, a state license and a pharmacist you can reach.[16]

Does semaglutide work the same as Ozempic?

The approved brands contain the same active ingredient, so they share a mechanism: semaglutide acts on appetite centers in the brain, raises insulin release when blood sugar is high, lowers glucagon and slows stomach emptying.[3] They differ in dose, and so in results: people on the higher Wegovy doses were studied for body weight, people on Ozempic for blood sugar and heart and kidney outcomes.[3][2]

For a compounded product, nobody can say. It has no trials of its own, and whether it contains what the label says depends on the pharmacy that made it.[7][10]

Semaglutide and Ozempic side effects

All semaglutide labels carry the same boxed warning about thyroid C-cell tumors, seen in rodents, human relevance unknown, and the same core warnings: pancreatitis, gallbladder disease, low blood sugar with insulin or a sulfonylurea, kidney injury from dehydration, serious allergic reactions, diabetic eye disease and breathing in stomach contents under anesthesia.[3][2][4] Digestive reactions are the most common, and their rates rise with dose:

Most common, drug vs placebo Ozempic 1 mg (type 2 diabetes) Wegovy 2.4 mg injection
Nausea 20.3% vs 6.1% 44% vs 16%
Vomiting 9.2% vs 2.3% 24% vs 6%
Diarrhea 8.8% vs 1.9% 30% vs 16%
Abdominal pain 5.7% vs 4.6% 20% vs 10%

Sources: the two labels.[2][3] The figures come from different trials in different people, so they are not a ranking; the labels say rates from one set of trials cannot be compared directly with another's.[3]

How much do Ozempic and other semaglutide brands cost?

Prices change often. These are Novo Nordisk's own figures as of November 13, 2026. We do not quote compounded prices.

  • Ozempic: the pen is $349 a month for 0.25 to 1 mg and $499 for 2 mg, with new patients paying $199 for two fills; Ozempic tablets are $149, $199 and $299 by strength. With commercial insurance that covers it, as little as $25 with Novo's savings card.[17]
  • Wegovy: $349 a month for the injection from 0.25 to 2.4 mg, $399 for 7.2 mg, and $149 to $299 for the pill by strength.[18]
  • List price: Novo Nordisk will cut the list price of Wegovy, Ozempic and Rybelsus to $675 a month from January 1, 2027. It said the change does not affect self-pay prices.[19]

What to eat on semaglutide

The labels pair semaglutide with a reduced-calorie diet and more activity but name no diet.[3] The 2025 joint advisory from four US medical and nutrition societies sets the priorities: protein first, small nutrient-dense meals, fiber from food, deliberate fluids and strength training to protect lean mass.[20] Our pages go one question at a time:

For transparency about why this page exists on our site: we make one product, Zornava Replenish, a lemon-lime daily hydration and nutrient powder for lighter appetite days, including for people on GLP-1 medications. It is a dietary supplement, not a medication, and it does not replace or imitate any medicine on this page. It is not on sale yet; early access opens February 9, 2027, and the early-access list is open now.

Frequently asked questions

Is semaglutide the same as Ozempic?

Ozempic is a brand of semaglutide, made by Novo Nordisk and approved for type 2 diabetes. Semaglutide is the active ingredient, and Novo also sells it as Wegovy and Rybelsus. Products sold simply as "semaglutide" are usually compounded and are not FDA-approved.

Is there a generic Ozempic?

Not on sale in the US as of November 13, 2026. One generic semaglutide injection has tentative approval from the FDA, dated April 7, 2026, and a tentative approval does not allow the product to be marketed. Compounded semaglutide is not a generic.

Is compounded semaglutide the same as Ozempic?

No. The FDA says compounded drugs are not FDA-approved and that it does not check their safety, effectiveness or quality before they are sold. It tells telehealth companies not to call a compounded drug a generic or the same as an approved drug, and some compounders have used salt forms that the FDA calls different active ingredients.

Are Ozempic and Wegovy the same drug?

They contain the same active ingredient, semaglutide, but they are separate products. Ozempic is approved for type 2 diabetes, up to 2 mg a week. Wegovy is approved for chronic weight management, heart risk and MASH, with a maintenance dose of 2.4 mg and up to 7.2 mg for adults.

Is Ozempic approved for weight management?

No. Ozempic is approved for type 2 diabetes and for heart and kidney risk in type 2 diabetes. The semaglutide product approved for chronic weight management is Wegovy, as an injection and, since December 22, 2025, as a daily pill.

What is semaglutide sodium?

A salt form of semaglutide that some compounders have used. The FDA says semaglutide sodium and semaglutide acetate are different active ingredients from the one in the approved drugs, and that it knows of no lawful basis for compounding with them.

Is Rybelsus the same as Ozempic?

Both are semaglutide from Novo Nordisk for type 2 diabetes. Rybelsus is a daily tablet; Ozempic is a weekly injection and, since a newer tablet formulation, also a daily tablet. Their shared label says Rybelsus and Ozempic tablets are not interchangeable milligram for milligram.

How much does Ozempic cost without insurance?

As of November 13, 2026, Novo Nordisk's self-pay price for the Ozempic pen is $349 a month for 0.25 to 1 mg and $499 for 2 mg, and Ozempic tablets are $149 to $299 by strength. Prices change often.

References

  1. US Food and Drug Administration. Drugs@FDA: Ozempic (NDA 209637), Rybelsus and Ozempic tablets (NDA 213051), Wegovy injection (NDA 215256) and Wegovy tablets (NDA 218316), approval history. Drugs@FDA. 2026. accessdata.fda.gov. Approval dates read from the Drugs@FDA submission records via openFDA (api.fda.gov/drug/drugsfda.json) and checked against the FDA approval letters for NDA 215256 S-005, S-023 and S-029, NDA 213051 S-020 and S-024, and NDA 218316 (original approval 2025-12-22). ↩︎
  2. Novo Nordisk. Ozempic (semaglutide) injection, prescribing information and Medication Guide. DailyMed, US National Library of Medicine. 2026. (sections 1, 2, 5, 6.1 and 14) DailyMed. ↩︎
  3. Novo Nordisk. Wegovy (semaglutide) injection and tablets, prescribing information and Medication Guide. DailyMed, US National Library of Medicine. 2026. (boxed warning; sections 1, 2, 5, 6.1, 12 and 14) DailyMed. ↩︎
  4. Novo Nordisk. Rybelsus and Ozempic (semaglutide) tablets, prescribing information and Medication Guide. DailyMed, US National Library of Medicine. 2026. (sections 1–3 and 5) DailyMed. SPL read via DailyMed services (label effective 2026-01-30). ↩︎
  5. US Food and Drug Administration. Drugs@FDA: ANDA 220314, semaglutide injection (2 mg/3 mL, 4 mg/3 mL, 8 mg/3 mL). Drugs@FDA. 2026. accessdata.fda.gov. Tentative approval 2026-04-07; marketing status None (Tentative Approval). openFDA lists no other semaglutide ANDA as of 2026-11-13. ↩︎
  6. US Food and Drug Administration. Drugs@FDA Glossary of Terms. fda.gov. fda.gov. Definition of tentative approval. ↩︎
  7. US Food and Drug Administration. Compounding and the FDA: Questions and Answers. fda.gov. 2025. fda.gov. Page read (content current as of 09/16/2025). ↩︎
  8. US Food and Drug Administration. FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s. fda.gov. 2026. fda.gov. Press announcement of 2026-03-03. ↩︎
  9. US Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. fda.gov. 2024. fda.gov. Page read (content current as of 07/26/2024). ↩︎
  10. US Food and Drug Administration. fda.gov. 2026. fda.gov. Page read (content current as of 10/01/2026). ↩︎
  11. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989–1002. PubMed. PMID: 33567185. doi: 10.1056/nejmoa2032183. ↩︎
  12. US Food and Drug Administration. FDA to Telehealth Companies: What to Know When Promoting Compounded Drugs. fda.gov. 2026. fda.gov. Page read (content current as of 06/15/2026). ↩︎
  13. US Food and Drug Administration. Declaratory order: resolution of the semaglutide injection product shortage. fda.gov. 2025. fda.gov. Order dated 2025-02-21; gives shortage-list dates of 2022-03-31 (Wegovy) and 2022-08-23 (Ozempic). ↩︎
  14. US Food and Drug Administration. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. fda.gov. 2026. fda.gov. Page read (content current as of 04/01/2026); dated entries from 2024-10-02 onward. ↩︎
  15. US Food and Drug Administration. Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry. fda.gov. 2018. (sections on prescriber determinations and price) fda.gov. Final guidance of January 2018. ↩︎
  16. US Food and Drug Administration. BeSafeRx: Considering an Online Pharmacy? fda.gov. 2020. fda.gov. Page read (content current as of 09/21/2020). ↩︎
  17. Novo Nordisk. Save on Ozempic. ozempic.com. 2026. ozempic.com. Maker price page read 2026-11-13. ↩︎
  18. Novo Nordisk. Wegovy savings offer and self-pay pricing. NovoCare. 2026. novocare.com. Maker price page read 2026-11-13; prices stated to be updated after 2026-12-31. ↩︎
  19. Novo Nordisk. Novo Nordisk announces significant reduction in US list price for Wegovy, Ozempic, and Rybelsus (semaglutide medicines), building on continued efforts to expand access. Press release (PR Newswire, via BioSpace). 2026. biospace.com. Press release of 2026-02-24. List price change effective 2027-01-01. ↩︎
  20. Mozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity (Silver Spring). 2025;33(8):1475–1503. (sections on protein, fluids, fiber and resistance training) Full text. PMID: 40445127. doi: 10.1002/oby.24336. ↩︎
Share this
← All Lighter Days articles

Free guide

The GLP-1 eating plan

Eight pages to print and keep, built protein first for days when appetite is small. Sourced, like everything on Lighter Days.

  • Seven days of four small meals, with protein and fiber counted
  • A food list: what to eat more often, and what to go easy on
  • A shopping list and a page to take to your prescriber or dietitian

You’ll also get early access to Replenish and a few emails a month. Unsubscribe any time.